e-Drug3D

570

ESTAZOLAM


INN
ESTAZOLAM

cas 29975-16-4
CLASS

NERVOUS SYSTEM
HYPNOTIC
ANXIOLYTIC
MANAGEMENT OF INSOMNIA
GABA MODULATORS
BENZODIAZEPINE

ROUTE (list)

ORAL

ATC code

N05CD04

PK parameters

Tmax 2 HOUR
PPB 93 PERCENT
t1/2 17 HOUR

Solubility

PRACTICALLY INSOLUBLE IN WATER


Target

TARGET GABA RECEPTOR

DrugCentral

GABA-A receptor alpha-1,beta-2,gamma-2 UNIPROT P14867 GABRA1

GABA-A receptor alpha-2,beta-3,gamma-2 UNIPROT P18507 GABRG2

Download SDF file 8-chloro-6-phenyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine

Formula:
C16H11ClN4

Calculated chemical properties:

MW 294.74
NB_atoms 21
XLogP 3.27
PSA 36.612
NB_HD 0
NB_HA 4
fsp3 0.06
Lipinski(0=no;1=yes) 1

FDA
NDA 019080 (pdf not found) INN (ESTAZOLAM) PROSOM (ABBOTT) APPROVAL= AP YEAR= 1990 DISCONTINUED
NDA 074818 (pdf not found) INN (ESTAZOLAM) ESTAZOLAM (WATSON LABS) APPROVAL= AP YEAR= 1997
NDA 074826 (pdf not found) INN (ESTAZOLAM) ESTAZOLAM (NOVITIUM PHARMA) APPROVAL= AP YEAR= 1997
NDA 074921 (pdf not found) INN (ESTAZOLAM) ESTAZOLAM (DR REDDYS LABS SA) APPROVAL= AP YEAR= 1997

Other links:

PubChem
ChemicalProbes

U.S. repository of Clinical Trials

VigiAccess
SIDER side effects

ChemSynthesis
Patent@SureChEMBL